We are live on ! Find out more
CDLX icon

Cardlytics

144 hedge funds and large institutions have $516M invested in Cardlytics in 2024 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 52 increasing their positions, 33 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 19

85% more capital invested

Capital invested by funds: $279M → $516M (+$236M)

58% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 33

50% more funds holding in top 10

Funds holding in top 10: 69 (+3)

16% more funds holding

Funds holding: 124144 (+20)

0.35% more ownership

Funds ownership: 7.73%8.08% (+0.35%)

23% less call options, than puts

Call options by funds: $17.2M | Put options by funds: $22.3M

Holders
144
Holders Change
+20
Holders Change %
+16.13%
% of All Funds
2.07%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.13%
New
39
Increased
52
Reduced
33
Closed
19
Calls
$17.2M
Puts
$22.3M
Net Calls
-$5.08M
Net Calls Change
-$903K

CDLX Hedge Fund Activity: Q1 2024 in Review

144 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q1 2024, worth a combined $516M — up 85% from $279M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new CDLX positions and 19 closed out — a net gain of 20 holders — while 52 added to existing stakes and 33 trimmed.

The largest buyer was CAS Investment Partners, adding an estimated $8.09M. The largest seller was Brightlight Capital Management, cutting an estimated $2.53M.

  • 144 institutional investors held Cardlytics (CDLX) as of Q1 2024, up from 124 in Q4 2023.
  • Funds reported $516M of Cardlytics stock for Q1 2024, up 85% quarter-over-quarter.
  • 39 funds opened new Cardlytics positions in Q1 2024 and 19 closed out, a net change of +20 holders.
  • The largest Cardlytics buyer in Q1 2024 was CAS Investment Partners, an estimated $8.09M added.
  • The largest Cardlytics seller in Q1 2024 was Brightlight Capital Management, an estimated $2.53M sold.

Based on aggregated 13F filings for Q1 2024.